← All trials
NCT04351724
Phase 2/Phase 3Interventional
Trials that are a combination of phases 2 and 3.
View on ClinicalTrials.gov ↗Timeline
- Start date
- Apr 16, 2020
- Primary completion
- Dec 1, 2020
- Completion date
- Dec 31, 2020
- First posted
- Apr 17, 2020
- Last posted
- Apr 17, 2020
- Enrollment
- 500
- Arms / groups
- 9 / —
- Source
- AACT · ingestion pipeline
Sponsors
- Medical University of ViennaLead sponsor
- Wilhelminenspital der Stadt WienCollaborator
- Medical University of ViennaReponsible party - principal investigator
- Medical University of ViennaOverall official - principal investigator
- Medical University InnsbruckCollaborator
- Hospital HietzingCollaborator
- Kaiser Franz Josef HospitalCollaborator
- Otto Wagner HospitalCollaborator
- SMZ-Ost DonauspitalCollaborator
Drugs studied
Indications studied
CDEK-curated fields only — the ClinicalTrials.gov results mirror (baseline measures, adverse events, participant flow) is a separate, currently-dormant pipeline; see MIGRATION_PLAN.md.